Pediatr Gastroenterol Hepatol Nutr.  2019 Nov;22(6):545-553. 10.5223/pghn.2019.22.6.545.

Lactobacillus reuteri DSM 17938 Improves Feeding Intolerance in Preterm Infants

• Kaban RK
• Wardhana
• Hegar B
• Rohsiswatmo R
• Handryastuti S
• Amelia N
• Muktiarti
• Indrio F
• Vandenplas Y

• KMID: 2462094
• DOI: http://doi.org/10.5223/pghn.2019.22.6.545

Abstract

PURPOSE
Feeding tolerance is extremely important in preterm infants. This study aimed to evaluate whether preterm infants receiving Lactobacillus reuteri DSM 17938 would develop fewer symptoms of feeding intolerance. Secondary outcomes were duration of parenteral nutrition, time to reach full feeding, length of hospital stay, sepsis, necrotizing enterocolitis (NEC), diarrhea, and mortality.
METHODS
This double-blind randomized controlled trial of L. reuteri DSM 17938 versus placebo included 94 neonates with a gestational age of 28-34 weeks and birth weight of 1,000-1,800 g.
RESULTS
Feeding intolerance (vomiting and/or distension) was less common in the probiotic group than in the placebo group (8.5% vs. 25.5%; relative risk, 0.33; 95% confidence interval, 0.12-0.96; p=0.03). No significant intergroup differences were found in proven sepsis, time to reach full feeding, length of hospital stay, or diarrhea. The prevalence of NEC (stages 2 and 3) was 6.4% in the placebo group vs. 0% in the probiotic group (relative risk, 1.07; 95% confidence interval, 0.99-1.15; p=0.24). Mortality rates were 2.1% in the probiotic group and 8.5% in the placebo group, p=0.36).
CONCLUSION
The administration of L. reuteri DSM 17938 to preterm infants was safe and significantly reduced feeding intolerance. No significant differences were found in any other secondary outcomes.

Keyword

Lactobacillus reuteri; Preterm; Feeding intolerance

MeSH Terms

Birth Weight
Diarrhea
Enterocolitis, Necrotizing
Gestational Age
Humans
Infant, Newborn
Infant, Premature*
Lactobacillus reuteri*
Lactobacillus*
Length of Stay
Mortality
Parenteral Nutrition
Prevalence
Probiotics
Sepsis

Reference

1. de Vrese M, Schrezenmeir J. Probiotics, prebiotics, and synbiotics. Adv Biochem Eng Biotechnol. 2008; 111:1–66.

2. Sinkiewicz G, Ljunggren L. Occurrence of Lactobacillus reuteri in human breast milk. Microb Ecol Health Dis. 2008; 20:112–116.

3. Thomas DW, Greer FR. American Academy of Pediatrics Committee on Nutrition. American Academy of Pediatrics Section on Gastroenterology, Hepatology, and Nutrition. Probiotics and prebiotics in pediatrics. Pediatrics. 2010; 126:1217–1231.

4. Pietzak M. Bacterial colonization of the neonatal gut. J Pediatr Gastroenterol Nutr. 2004; 38:389–391.

5. Reuter G. The Lactobacillus and Bifidobacterium microflora of the human intestine: composition and succession. Curr Issues Intest Microbiol. 2001; 2:43–53.

6. Huda S, Chaudhery S, Ibrahim H, Pramanik A. Neonatal necrotizing enterocolitis: clinical challenges, pathophysiology and management. Pathophysiology. 2014; 21:3–12.

7. Lin HC, Hsu CH, Chen HL, Chung MY, Hsu JF, Lien RI, et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial. Pediatrics. 2008; 122:693–700.

8. Wu SF, Caplan M, Lin HC. Necrotizing enterocolitis: old problem with new hope. Pediatr Neonatol. 2012; 53:158–163.

9. Chu A, Hageman JR, Caplan MS. Necrotizing enterocolitis predictive markers and preventive strategies. Neoreviews. 2013; 14:e113–e120.

10. Shadkam MN, Jalalizadeh F, Nasiriani K. Effects of probiotic Lactobacillus reuteri (DSM 17938) on the incidence of necrotizing enterocolitis in very low birth weight premature infants. Iran J Neonatol. 2015; 6:15–20.

11. Athalye-Jape G, Rao S, Patole S. Lactobacillus reuteri DSM 17938 as a probiotic for preterm neonates: a strain-specific systematic review. JPEN J Parenter Enteral Nutr. 2016; 40:783–794.

12. Rojas MA, Lozano JM, Rojas MX, Rodriguez VA, Rondon MA, Bastidas JA, et al. Prophylactic probiotics to prevent death and nosocomial infection in preterm infants. Pediatrics. 2012; 130:e1113–e1120.

13. Indrio F, Riezzo G, Raimondi F, Bisceglia M, Cavallo L, Francavilla R. The effects of probiotics on feeding tolerance, bowel habits, and gastrointestinal motility in preterm newborns. J Pediatr. 2008; 152:801–806.

14. Rao SC, Athalye-Jape GK, Deshpande GC, Simmer KN, Patole SK. Probiotic supplementation and lateonset sepsis in preterm infants: a meta-analysis. Pediatrics. 2016; 137:e20153684.

15. Oncel MY, Sari FN, Arayici S, Guzoglu N, Erdeve O, Uras N, et al. Lactobacillus reuteri for the prevention of necrotising enterocolitis in very low birthweight infants: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed. 2014; 99:F110–5.

16. AlFaleh K, Anabrees J. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev. 2014; (4):CD005496.

17. Hunter C, Dimaguila MA, Gal P, Wimmer JE Jr, Ransom JL, Carlos RQ, et al. Effect of routine probiotic, Lactobacillus reuteri DSM 17938, use on rates of necrotizing enterocolitis in neonates with birthweight <1000 grams: a sequential analysis. BMC Pediatr. 2012; 12:142.

18. Lee JH. An update on necrotizing enterocolitis: pathogenesis and preventive strategies. Korean J Pediatr. 2011; 54:368–372.

19. Doron S, Snydman DR. Risk and safety of probiotics. Clin Infect Dis. 2015; 60:Suppl 2. S129–S134.

20. Vahabnezhad E, Mochon AB, Wozniak LJ, Ziring DA. Lactobacillus bacteremia associated with probiotic use in a pediatric patient with ulcerative colitis. J Clin Gastroenterol. 2013; 47:437–439.

21. Kaban RK. Analisis dampak perbedaan pajanan konsentrasi oksigen awal pada resusitasi bayi prematur terhadap displasia bronkopulmonal, integritas mukosa, dan mikrobiota usus, disertasi. Jakarta: Universitas Indonesia;2016.

22. Sjarif DR, Rohsiswatmo R, Rundjan L, Yuliarti K. Panduan berbasis bukti: asuhan nutrisi untuk bayi prematur. Jakarta: Departemen Ilmu Kesehatan Anak FKUI-RSCM;2016.

23. Khashana A, Moussa R. Incidence of feeding intolerance in preterm neonates in neonatal intensive care units, Port Said, Egypt. J Clin Neonatol. 2016; 5:230–232.

24. Dominguez KM, Moss RL. Necrotizing enterocolitis. Clin Perinatol. 2012; 39:387–401.

25. Christensen RD, Lambert DK, Baer VL, Gordon PV. Necrotizing enterocolitis in term infants. Clin Perinatol. 2013; 40:69–78.

26. Wejryd E, Marchini G, Frimmel V, Jonsson B, Abrahamsson T. Probiotics promoted head growth in extremely low birthweight infants in a double-blind placebo-controlled trial. Acta Paediatr. 2019; 108:62–69.

27. Schanler RJ. Human milk is the feeding strategy to prevent necrotizing enterocolitis. Curr Pediatr Rep. 2014; 2:264–268.

28. van den Akker CHP, van Goudoever JB, Szajewska H, Embleton ND, Hojsak I, Reid D. ESPGHAN Working Group for Probiotics, Prebiotics & Committee on Nutrition. Probiotics for preterm infants: a strainspecific systematic review and network meta-analysis. J Pediatr Gastroenterol Nutr. 2018; 67:103–122.

29. Wang Q, Dong J, Zhu Y. Probiotic supplement reduces risk of necrotizing enterocolitis and mortality in preterm very low-birth-weight infants: an updated meta-analysis of 20 randomized, controlled trials. J Pediatr Surg. 2012; 47:241–248.

30. Escribano E, Zozaya C, Madero R, Sánchez L, van Goudoever J, Rodríguez JM, et al. Increased incidence of necrotizing enterocolitis associated with routine administration of Infloran™ in extremely preterm infants. Benef Microbes. 2018; 9:683–690.

31. Romeo MG, Romeo DM, Trovato L, Oliveri S, Palermo F, Cota F, et al. Role of probiotics in the prevention of the enteric colonization by Candida in preterm newborns: incidence of late-onset sepsis and neurological outcome. J Perinatol. 2011; 31:63–69.

32. Ofek Shlomai N, Deshpande G, Rao S, Patole S. Probiotics for preterm neonates: what will it take to change clinical practice? Neonatology. 2014; 105:64–70.

33. Indrio F, Riezzo G, Tafuri S, Ficarella M, Carlucci B, Bisceglia M, et al. Probiotic supplementation in preterm: feeding intolerance and hospital cost. Nutrients. 2017; 9:E965.

34. Pabst O, Cerovic V, Hornef M. Secretory IgA in the coordination of establishment and maintenance of the microbiota. Trends Immunol. 2016; 37:287–296.